DUBLIN--(BUSINESS WIRE)--The "Global Cardiac Pacemakers Market - Segmented by Type (Implantable and External), and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
The increasing prevalence of heart diseases and ageing population are driving the market. According to Centers for Disease Control and Prevention (CDC) statistics, more than three million people in the United States suffer from atrial fibrillation, which is the most common type of abnormal heart rhythm, and the number is expected to quadruple by 2050.
Other factors that are driving the market growth include a favorable reimbursement scenario and technological advancements in the field of pacemakers and minimally invasive surgeries.
- Medtronic received FDA's expanded indication for SelectSecure(TM) MRI SureScan(TM) pacing lead for bundle site stimulation.
- Abbott Inc. (St. Jude Medical)
- Medtronic PLC
- Boston Scientific Corporation
- Sorin Group
- Lepu medical Co. Ltd.
- Zoll medical corporation
- Biotronik SE & Co. KG
- Medico SpA
Key Topics Covered
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Market Dynamics
7. Market Segmentation
8. Key Players and Competitive Landscape
9. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/2rbxds/cardiac?w=4